According to UBS, now may be an opportune time to jump into the rail sector ahead of first-quarter earnings releases of several of the top players this month.
“Rail volumes have generally been better than expected in Q1 with CNI, NSC, and KSU realizing stronger volume growth while the mix appears supportive for CSX and UNP,” said UBS analyst Thomas Wadewitz.
The Swiss bank said it was raising first-quarter estimates on four of the six rails it covers, with updated estimates above consensus on Canadian National Railway (USA) (NYSE: CNI), CSX Corporation (NASDAQ: CSX) and Kansas City Southern (NYSE: KSU), which is seen to show upside against low expectations.
Rail industry stocks may be benefitting from low expectations, however, there has been solid industry volume growth of 4.5 percent year-over-year in Q1, which has been supported by strength in coal and grain, as well as steel and frac sand. UBS is anticipating upside in Q1 for rail stocks, despite a notable diesel fuel headwind given the favorable outlook commentary seen surrounding the industry. Continued growth in exporting of coal is also expected given recent weather disruptions causing rail operation delays in Australia.
“We believe the combination of an improved volume trend, a modest upside EPS report, and a decline in broader concern about trade could support attractive upside potential for KSU in the near term. We also expect 1Q EPS/ the conf call to be a catalyst for CSX stock driven by initial comments from CSX’s new CEO, which are likely to provide high level perspective on the opportunity for improvement in CSX’s large network of classification yards,” concluded Wadewitz.
Rail Stock Woes: Margin Management And The Law Of Diminishing Returns
Which Rail Stock Should You Board? Breaking Down Wells Fargo's Initiation In The Sector
Latest Ratings for CNI
|Jan 2017||Bank of America||Upgrades||Underperform||Neutral|
|Jan 2017||Raymond James||Upgrades||Market Perform||Outperform|
|Oct 2016||Seaport Global||Initiates Coverage On||Neutral|
View More Analyst Ratings for CNI
View the Latest Analyst Ratings
See more from Benzinga
- Disappointment In Corvus Pharma Understandable, But Selloff May Have Been Overdone
- Teens Find 100-Year-Old Converse To Be Cooler Than Under Armour
- Why Netflix Shares Cannot Be Valued Using Traditional Metrics
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.